Navigation Links
PhRMA Launches Campaign to Raise Awareness of Success of Medicare Prescription Drug Benefit
Date:6/10/2009

WASHINGTON, June 10 /PRNewswire-USNewswire/ -- With the debate over comprehensive healthcare reform now in full swing, the Pharmaceutical Research and Manufacturers of America is launching a new national broadcast advertising campaign touting the importance and success of free-market initiatives such as the Medicare prescription drug benefit (Part D).

Medicare Part D continues to provide unprecedented coverage and choice for seniors and disabled Americans, according to national surveys. And most importantly, seniors are saving money on their medicines through the program, particularly those who need it the most. According to the Centers for Medicare and Medicaid Services (CMS), the average value of the Part D benefit, premium subsidy, and cost-sharing subsidy in 2009 will be $1,200 for the average beneficiary, and about $3,900 for low-income.

In fact, in 2009, approximately 97 percent of beneficiaries in a stand-alone plan have access to a monthly premium less or equal to the premium they paid in 2008, according to CMS. And every state offers a Medicare prescription drug plan with a premium of $23 or less.

A recent Medicare Today survey, cited in the commercial, shows overall satisfaction has grown from 78 percent at the start of the program in 2006, to 84 percent in 2009. In addition, the new commercial also pushes for comprehensive healthcare reform.

"There is a success story out there in healthcare, and we want people to know about it. Since its inception, the Medicare drug benefit has given beneficiaries unprecedented access to needed medications, at an affordable cost," said PhRMA Senior Vice President Ken Johnson.

Not only are Medicare beneficiaries saving significant money, so too are American taxpayers. In March 2009, the non-partisan Congressional Budget Office (CBO) released new baseline spending projections that reduced its 10-year forecast for the total
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. PhRMA Statement on Healthcare Reform Coalition
2. American Slide Chart/Perrygraf "SlideGuides" and "SpinGuides" Help Drug Companies Satisfy New PhRMA Guidelines
3. PhRMA Honors Gardasil(r) Researchers With Discoverers Award
4. AstraZenecas David Brennan Elected PhRMA Board Chairman
5. PhRMA Statement on Expansion of SCHIP
6. DIA/FDA/PhRMA Drug Safety Conference: Planning the Lifecycle of Safety Evaluation
7. Revised PhRMA Marketing Code Calls for More Educational Materials for Health Care Providers and Staff - Anatstat Health Education Can Help
8. Eisai Renews Its Commitment to Responsible Healthcare Community Interactions in Accordance with the Revised PhRMA Marketing Code
9. Johnson & Johnson Announces Commitment To Adopt Revised PhRMA Marketing Code for Responsible Interactions With Healthcare Professionals
10. PhRMA Revised Marketing Code Reinforces Commitment to Responsible Interactions With Healthcare Professionals
11. Richard T. Clark Elected PhRMA Board Chairman

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Newswire/--TheBartleHallConventionCenterwilltempor...10,whenKansasCityhoststhelatestinaseriesofmassivef...ceventhasthepotentialtobethebiggestoneyet,becausei...eekdaysinsteadofoveraweekend,"SheriWood,executived...oftheNationalAssociationofFreeClinics(NAFC). ,,...
(Date:11/25/2009)...PRNewswire-USNewswire/--AnarticlebyJanetWoodcock,M...search,titled"ADifficultBalance-PainManagement,Dru...heNewEnglandJournalofMedicine. ,, (Logo: http:/..., Inthearticle,WoodcockdiscussesFDAeffortstostr...oneeditandmanagingtherisksposedbyvariousanalgesics...
(Date:11/25/2009)...e of a statistically significant survival benefit ...gen receptor (ER)-positive tumors had high levels ...alpha S118-P), according to a brief communication ...e National Cancer Institute . , Approximately 50... Preclinical studies have shown that ER-alpha S118...
(Date:11/25/2009)...tion and treatment clinics to resume Monday, Nov. ...vember 25, 2009 -- Centegra Health System is conti...e shots at four Centegra Primary Care (CPC) vaccin...s arrived. The clinics are at CPC sites in Huntley...open as follows: ,   From 4:30 to 7:30...
(Date:11/25/2009)...ewswire-USNewswire/--TheAmericanAssociationforHome...,"S.2128,whichisdesignedtosubstantiallyimprovetool...billwasintroducedbySen.GeorgeLeMieux(R-Fla.). ,...anAssociationforHomecareoutlinedinits13-pointanti-...essinFebruary.Thoseprovisionsincludecallingforreal...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2
... Reynolds American,Inc. (NYSE: RAI ) will webcast...d-quarter 2008 financial results on Wednesday, Oct... Time., During the call, members of the Reynolds ...le online on a listen-only basis,at http://www.Re...
... "air burial," grave cairns, funeral mounds, mummi...ces sacred to one culture are often considered "od... example, were fascinated with the historian Herod...ontrary to the Greeks, treatment of their own dead...
...al concerns surrounding use of cells from embryos ...European researchers say they,ve figured out how t...onic-like stem cells. , The findings are the lates...acles associated with their use. , "The ability to...
...The National,Community Pharmacists Association (NC...-term incumbent representing North Carolina, for r... executive vice president and CEO of,NCPA, issued ...serve. That is why the,National Community Pharmaci...
...The National,Community Pharmacists Association (NC...m incumbent representing Arkansas, for re-election... vice president and CEO of NCPA,issued the followi...e National,Community Pharmacists Association stron...
...The National,Community Pharmacists Association (NC...rm incumbent representing Kansas, for re-election ...vice president and CEO of NCPA,issued the followin...National,Community Pharmacists Association strongl...
Other Medicine News:Health News:RAI to Webcast Third-Quarter 2008 Earnings Conference Call 2Health News:Deathways open doors to unexpected cultural practices 2Health News:Researchers Create Embryonic-Like Stem Cells From Human Testes 2Health News:Researchers Create Embryonic-Like Stem Cells From Human Testes 3Health News:Researchers Create Embryonic-Like Stem Cells From Human Testes 4
(Date:11/25/2009)....25/PRNewswire/--SwissrayInternational,Inc.aleadin...ems,announcedtodaythatitsoperationshavebeenacquire...owingSwissray,smedicalimagingbrand.Theacquisitioni...ntractsandinventory.After25yearsofsuccessandgrowth...icaladvancementswithstableandsteadygrowth. ,, "...
(Date:11/25/2009)...ire/--Reportlinker.comannouncesthatanewmarketresea...nagement-GlobalTrends ,, http://www.reportli...html ,, Widespreadavailabilityofgenericdrugs,e...rugshaveacceleratedthepaceofgrowthinthepainmanagem...recontinuetoshapedemandforservices,drugsanddevices...
(Date:11/25/2009)...v.25/PRNewswire/-- ChemoCentryx,Inc.,announcedtod...CT-1(theProspectiveRandomizedOralTherapyEvaluation...npatientswithmoderate-to-severeCrohn,sdiseasedemon...rabilityprofile.Thestudydemonstratedevidenceofclin...edasa70-pointdecreaseintheCrohn,sDiseaseActivityIn...
Breaking Medicine Technology:Swissray International Announces New Ownership 2Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5SXC Health Solutions announces pricing of upsized public offering of common shares 57606 1SXC Health Solutions announces pricing of upsized public offering of common shares 57606 2SXC Health Solutions announces pricing of upsized public offering of common shares 57606 3SXC Health Solutions announces pricing of upsized public offering of common shares 57606 4SXC Health Solutions announces pricing of upsized public offering of common shares 57606 5AstraZeneca Accepts Secretary of Defense Award for Supporting Employees Serving in National Guard and Reserve 57603 1AstraZeneca Accepts Secretary of Defense Award for Supporting Employees Serving in National Guard and Reserve 57603 2Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptam 14136 1Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptam 14136 2Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptam 14136 3
...--Apr 17, 2007 - A 9-month, randomized,double-bli...omparing a 40 mg dose of COPAXONE(R) given daily t...owed a 38 percent greater,reduction in inflammator...ce images (MRI) of the brain. In addition, patient...ean on-trial relapse rate,of 77 percent when compa...
...erican Association for Cancer Research,annual meet...-FirstCall/ --,Medarex, Inc. today presented precl...ity from two separate studies exploring the,effica...ti-CD70,antibody-drug conjugates. CD19 and CD70 ar...jugate approach to cancer therapy. They are,expres...
Other Medicine Technology:Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 2Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 3Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 4Data Published in Neurology Showed That Higher Dose of Copaxone,Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS) 5Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 2Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 3Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 4
MP20
... IntelliVue MP90 is designed to match the pace and...nts. Built on Philips strong heritage in patient m...nt displays has highly flexible screen configurati...-in clinical support tools such as Event Surveilla...
...xNet adds wireless capability to Welch Allyn's com... the Flexible Monitoring concept to provide vital ...o anywhere. FlexNet links multiple devices such as...reless bedside monitors to Acuity® Central Mon...
Spot Vital Signs
Medicine Products: